Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hipoglós
- Development stage
- Unknown
- Lead developer
- Laboratorios Andromaco
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Hipoglós is a well-established over-the-counter (OTC) topical ointment primarily used for the prevention and treatment of diaper dermatitis (diaper rash) and other minor skin irritations. Developed and marketed by Laboratorios Andromaco, the formulation typically combines zinc oxide, which serves as a protective physical barrier and mild astringent, with vitamins A (retinol) and D (ergocalciferol) to support skin regeneration and epithelial health. It is widely utilized in Latin American markets as a standard care product for infant skin protection and the management of superficial wounds or burns.
- Brand names
- Hipoglós
- Other names
- Hipoglos AndrómacoHipoglos Pomada
02
Targets
RAR (Retinoic acid receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Hipoglós.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hipoglós.